NCT07205419

Brief Summary

The objectives of this clinical trial are to explore the feasibility of the eye-tracking communication tool in alleviating communication barriers among non-verbal ICU patients. It will also preliminarily investigate the effectiveness of this tool in facilitating communication for these patients. Researchers will compare the eye-tracking communication tool with conventional techniques (such as body language, writing boards, etc.) to observe the feasibility and preliminary effectiveness of the eye-tracking communication tool in alleviating communication barriers. Participants will use an eye-tracking communication tool for augmentative communication for 2 consecutive days.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
23mo left

Started Jul 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Jul 2026Jun 2028

First Submitted

Initial submission to the registry

September 2, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

May 27, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

September 2, 2025

Last Update Submit

May 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Communication difficulty

    The degree of communication difficulty in non-verbal ICU patients will be assessed using the Ease of Communication Scale. This tool was revised by Menzel et al.in 1998 and has previously been used to assess communication difficulties among non-verbal patients in the ICU. The scale comprises 6 items, with response options ranging from 0 (no difficulty at all) to 4 (extreme difficulty). The total score ranges from 0 to 24, with higher scores indicating greater communication difficulties.

    up to 2days after enrollment

Secondary Outcomes (7)

  • Well-being and safety

    at 4:00 PM daily

  • Satisfaction of family members

    up to 2 days after enrollment

  • Communication burden of ICU healthcare professionals

    up to 2 days after enrollment

  • Nurses' compliance

    through study completion,an average of 2 year

  • Time spent training patients during initial use

    Day 1

  • +2 more secondary outcomes

Study Arms (2)

Control Group:conventional techniques group

NO INTERVENTION

Charge nurses will lead communication through conventional methods, including body language (e.g., pointing, nodding, shaking the head) or by providing writing boards for patients to write. Patients unable to write will communicate solely through body language.

Intervention Group

EXPERIMENTAL

Charge nurses will lead communication using the eye-tracking communication tool.

Device: Eye-Tracking communication tool

Interventions

The eye-tracking interactive interface designed based on evidence-based and co-design.The eye-tracking communication tool consists of an eye-tracker, a tablet, and a floor-standing stand. The tool will be placed at the patient's bedside 24 hours a day to facilitate real-time communication.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged ≥ 18 years
  • ICU stay ≥ 24 hours
  • unable to communicate through normal verbal means due to endotracheal intubation/tracheotomy, muscle or nerve injury, acute/chronic spinal cord injury, etc.
  • Richmond Agitation-Sedation Scale (RASS) score ranging from -1 to 1
  • able to comply with simple instructions for study participation

You may not qualify if:

  • blindness or inability to elevate the eyelids that preclude successful participation in eye-tracking interaction tasks
  • cognitive impairment limiting meaningful participation
  • severe psychological distress

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2025

First Posted

October 3, 2025

Study Start

July 1, 2026

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

June 30, 2028

Last Updated

May 27, 2026

Record last verified: 2026-05